Home › Funds › ACT Capital Partners, L.P. › ANL
ACT Capital Partners, L.P. position in ANL
ADLAI NORTYE LTD · Health Care
ACT Capital Partners, L.P. reported holding 24,400 shares of ANL (ADLAI NORTYE LTD) in its Q3 2026 13F filing — a position valued at US$430K, representing 0.29% of its reported portfolio and ranking #35 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR
How ACT Capital Partners, L.P.'s ANL position evolved
ACT Capital Partners, L.P. first disclosed a stake in ANL in Q3 2026 at 24,400 shares (US$430K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 24.40K | $430.40K | New |
About ANL and 13F data
ANL (ADLAI NORTYE LTD) is a Health Care company. 42 other funds we track also report a position in ANL — the largest reported positions include Cormorant Asset Management, LP (US$45.7M), Venrock Adviser, LLC (US$36.9M), MPM BioImpact LLC (US$22.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANL
- Cormorant Asset Management, LP 3.98M sh · $45.75M · Q2 2026
- Venrock Adviser, LLC 3.21M sh · $36.95M · Q2 2026
- MPM BioImpact LLC 1.94M sh · $22.27M · Q2 2026
- Casdin Capital 1.25M sh · $14.38M · Q2 2026
- ADAR1 Capital Management, LLC 1.02M sh · $11.70M · Q2 2026
- Octagon Capital Advisors LP 934.72K sh · $10.75M · Q2 2026
- Squadron Capital Management LLC 764.88K sh · $8.80M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 552.50K sh · $6.35M · Q2 2026
- BOONE CAPITAL MANAGEMENT LLC 258.39K sh · $2.97M · Q2 2026
- DAFNA Capital Management LLC 239.55K sh · $2.75M · Q2 2026
- Kalehua Capital Management LLC 226.41K sh · $2.60M · Q2 2026
- ACT CAPITAL MANAGEMENT, LLC 27.00K sh · $310.50K · Q2 2026
More on ACT Capital Partners, L.P.
FAQ
How long has ACT Capital Partners, L.P. held ANL?
ACT Capital Partners, L.P. has disclosed ANL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACT Capital Partners, L.P.'s current position in ANL?
As of Q3 2026, ACT Capital Partners, L.P. holds 24.40K shares of ANL (ADLAI NORTYE LTD), valued at $430.40K, representing 0.29% of its reported portfolio and ranking #35.
Has ACT Capital Partners, L.P. been buying or selling ANL?
In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in ANL.
Which other funds hold ANL?
Other major institutional holders of ANL include Cormorant Asset Management, LP, Venrock Adviser, LLC, MPM BioImpact LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.